8.22
전일 마감가:
$8.34
열려 있는:
$8.39
하루 거래량:
118.44K
Relative Volume:
0.83
시가총액:
$298.33M
수익:
$8.98M
순이익/손실:
$-31.39M
주가수익비율:
-6.1343
EPS:
-1.34
순현금흐름:
$-24.83M
1주 성능:
-2.61%
1개월 성능:
+8.87%
6개월 성능:
+42.76%
1년 성능:
+10.63%
프로파운드 메디컬 Stock (PROF) Company Profile
명칭
Profound Medical Corp
전화
647-476-1350
주소
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
PROF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PROF
Profound Medical Corp
|
8.22 | 302.68M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
프로파운드 메디컬 Stock (PROF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 개시 | Lake Street | Buy |
| 2024-07-16 | 업그레이드 | Stifel | Hold → Buy |
| 2023-11-28 | 개시 | Stifel | Hold |
| 2023-08-04 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-15 | 개시 | Jefferies | Buy |
모두보기
프로파운드 메디컬 주식(PROF)의 최신 뉴스
Profound Medical upsizes private placement to raise US$6.45 million - MSN
Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock? - Yahoo Finance
Profound Medical (PROF) Introduces TULSA-PRO at Mount Sinai Hosp - GuruFocus
Long Term Trading Analysis for (PRN) (PRN:CA) - Stock Traders Daily
Profound Medical Expands TULSA-PRO Use at Mount Sinai - TipRanks
AI-guided, incision-free prostate treatment debuts at Mount Sinai - Stock Titan
Profound Medical (TSE:PRN) Hits New 1-Year HighTime to Buy? - MarketBeat
Profound Medical Exceeds 2025 TULSA-PRO Installation Target and Grows Sales Pipeline - The Globe and Mail
Objective long/short (PRN) Report (PRN:CA) - Stock Traders Daily
Profound Medical Corp Surpasses 2025 TULSA-PRO® Installation Goal - TradingView — Track All Markets
Profound Medical (PROF) Surpasses Installation Goal with TULSA-P - GuruFocus
Profound Surpasses 2025 TULSA-PRO® Installed Base Goal - Investing News Network
Laser Focus WorldProfound Surpasses 2025 TULSA-PRO® Installed Base Goal - FinancialContent
How Profound Medical Corp. stock performs during Fed tightening cyclesJuly 2025 Closing Moves & AI Powered Buy and Sell Recommendations - Улправда
How To Trade (PRN) (PRN:CA) - Stock Traders Daily
Will Profound Medical Corp. stock reach all time highs in 2025Portfolio Gains Report & Low Risk High Win Rate Picks - Улправда
Why Profound Medical Corp. stock attracts high net worth investors2025 Buyback Activity & AI Powered Market Entry Ideas - Улправда
Why Profound Medical Corp. stock remains on buy listsOptions Play & Fast Gain Swing Trade Alerts - Улправда
Profound Medical (NASDAQ:PROF) Trading 5.8% HigherHere's What Happened - MarketBeat
Can Profound Medical Corp. stock deliver sustainable ROEStock Split Announcements & Make Confident Moves With Forecasting Models - Улправда
Profound Medical (PROF) Sees Price Target Boost by Lake Street | - GuruFocus
Profound Medical stock price target raised to $12 by Lake Street - Investing.com Canada
Profound Medical raises US$6.45 million in Canadian private placement - MSN
Profound Medical Corp Launches TULSA-PRO at Johns Hopkins - TradingView — Track All Markets
Profound Medical Reclaims Canadian Distribution Rights for TULSA-PRO® - MSN
Profound Medical’s TULSA-PRO Marks First Commercial Case at Johns Hopkins - TipRanks
Profound Medical (PROF) Marks Milestone at Johns Hopkins Hospita - GuruFocus
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case - The Manila Times
Incision-free prostate cancer procedure debuts at Johns Hopkins - Stock Titan
(PRN) Long Term Investment Analysis (PRN:CA) - Stock Traders Daily
Profound Medical announces pricing of up to $40 million financing - MSN
Highs Report: How BRZE stock reacts to job market dataPortfolio Risk Report & Daily Growth Stock Investment Tips - moha.gov.vn
Trading (PRN) With Integrated Risk Controls (PRN:CA) - Stock Traders Daily
Profound Medical Secures $36 Million to Expand Commercialization of AI-Powered Prostate Treatment - citybuzz -
Sentiment Recap: How Profound Medical Corp stock valuations compare to rivalsSell Signal & Trade Opportunity Analysis - moha.gov.vn
Profound Medical Corp closes private placement - Medical Buyer
Profound Medical Signs Subscription Agreement With Canadian Investors - TradingView — Track All Markets
Insider Spends US$139k Buying More Shares In Profound Medical - Yahoo Finance
About Us - FinancialContent
Profound Medical Raises US$6.45 Million in Canadian Private Placement - TipRanks
Profound Medical announces closing of private placement - MarketScreener
Profound Medical Corp. Announces Closing of Private Placement - The Manila Times
Profound Medical Corp. Brief: Announcing Closing of Private Placement - MarketScreener
Star TribuneProfound Medical Corp. Announces Closing of Private Placement - FinancialContent
Published on: 2025-12-30 05:11:53 - Bộ Nội Vụ
(PRN) Trading Report (PRN:CA) - Stock Traders Daily
Profound Medical increases private placement to $6.45M - MSN
Profound Medical (TSE:PRN) Trading 2.1% Higher – Still a Buy? - Defense World
(PRN) Pivots Trading Plans and Risk Controls (PRN:CA) - Stock Traders Daily
Profound Medical Corp Upsizes Private Placement to $6.45M to Fund Sales, R&D Expansion - marketscreener.com
프로파운드 메디컬 (PROF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
프로파운드 메디컬 주식 (PROF) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
자본화:
|
볼륨(24시간):